Tolvaptan

doi:10.1038/nrd2946

2009-08-01

PRE

DOI：10.1038/nrd2946

原文求助

摘要

Keyword:

VASOPRESSIN V-2-RECEPTOR ANTAGONIST

V-2 RECEPTOR ANTAGONIST

ORAL TOLVAPTAN

HEART-FAILURE

HYPONATREMIA

POTENT

OPC-41061

RATS

AI总结

对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Nature Reviews Drug Discovery

IF:

101.8

论文数:

5.1K

被引数:

5.3W

机构

暂无机构信息

引用论文

Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2007-03-28

1.2K

PREAI

Konstam, Marvin A.; Gheorghiade, Mihai; Burnett, John C., Jr.; Grinfeld, Liliana; Maggioni, Aldo P.; Swedberg, Karl; Udelson, James E.; Zannad, Faiez; Cook, Thomas; Ouyang, John; Zimmer, Christopher; Orlandi, Cesare

Clustering-based Communication Backbone for Large Scale UAV Networks

2018 14th International Conference on Mobile Ad-Hoc and Sensor Networks (MSN)

IF0

2018-12-01

PREAI

Hai Yu; Hejiao Huang; Xiaohua Jia

The role of unmanned aerial vehicles and mmWave in 5G: Recent advances and challenges

Transactions on Emerging Telecommunications Technologies

IF0

2021-03-10

PREAI

Shah Khalid Khan; Usman Naseem; Haris Siraj; Imran Razzak; Muhammad Imran

Estimating Radar Detection Coverage Probability of Targets in a Cluttered Environment Using Stochastic Geometry

2020 IEEE International Radar Conference (RADAR)

IF0

2020-04-01

PREAI

Shobha Sundar Ram; Gaurav Singh; Gourab Ghatak

Tumour HER2 protein in breast cancer and family history

The Lancet

IF0

1993-05-01

PREAI

Steven Lehrer; Patricia Lee; Paul Tartter; Steven Brower

Compressive sensing for cluster structured sparse signals: variational Bayes approach

IET Signal Processing

IF0

2016-09-01

OAAI

Lei Yu; Chen Wei; Jinyuan Jia; Hong Sun

7-chloro-5-hydroxy-1-[2-methyl-4-(2-metaminobenzoyl]-amino)benzoyl]-2,3,4,5-5-tetrahydro-1H-1-benzazepine (OPC-41061):: A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

1999-08-01

126

PREAI

Kondo, K; Ogawa, H; Yamashita, H; Miyamoto, H; Tanaka, M; Nakaya, K; Kitano, K; Yamamura, Y; Nakamura, S; Onogawa, T; Mori, T; Tominaga, M

Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia

ENDOCRINOLOGY

IF3.3

2005-07-01

OAAI

Miyazaki, T; Yamamura, Y; Onogawa, T; Nakamura, S; Kinoshita, S; Nakayama, S; Fujiki, H; Mori, T

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2006-11-16

883

OAAI

Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare

Therapeutic potential of vasopressin receptor antagonists

DRUGS

IF14.4

2007-01-01

PREAI

Ali, Farhan; Guglin, Maya; Vaitkevicius, Peter; Ghali, Jalal K.

没有更多内容